Cita APA

Bhatnagar, B., Eisfeld, A., Nicolet, D., Mrózek, K., Blachly, J. S., Orwick, S., . . . Byrd, J. C. (2016). Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia. Br J Haematol.

Chicago Style Citation

Bhatnagar, Bhavana, et al. "Persistence of DNMT3A R882 Mutations During Remission Does Not Adversely Affect Outcomes of Patients With Acute Myeloid Leukaemia." Br J Haematol 2016.

Cita MLA

Bhatnagar, Bhavana, et al. "Persistence of DNMT3A R882 Mutations During Remission Does Not Adversely Affect Outcomes of Patients With Acute Myeloid Leukaemia." Br J Haematol 2016.